Erasca, Inc. financial data

Symbol
ERAS on Nasdaq
Location
10835 Road To The Cure, Suite 140, San Diego, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.09K % -12.2%
Debt-to-equity 19.2 % -7.78%
Return On Equity -33.1 % +21.7%
Return On Assets -27.8 % +20.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 284M shares +0.35%
Common Stock, Shares, Outstanding 284M shares +0.36%
Entity Public Float 563M USD +89.5%
Common Stock, Value, Issued 28K USD 0%
Weighted Average Number of Shares Outstanding, Basic 284M shares +0.46%
Weighted Average Number of Shares Outstanding, Diluted 284M shares +0.46%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 38.8M USD -5.89%
Operating Income (Loss) -144M USD +19%
Nonoperating Income (Expense) 16.3M USD -12.4%
Net Income (Loss) Attributable to Parent -128M USD +19.8%
Earnings Per Share, Basic 0 USD/shares +51.8%
Earnings Per Share, Diluted 0 USD/shares +51.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 70.2M USD +1.95%
Marketable Securities, Current 218M USD -12.7%
Cash, Cash Equivalents, and Short-term Investments 362M USD +13.6%
Assets, Current 300M USD -9.16%
Property, Plant and Equipment, Net 14M USD -18.2%
Operating Lease, Right-of-Use Asset 30.1M USD -8.54%
Other Assets, Noncurrent 1.97M USD -49.3%
Assets 420M USD -20.5%
Accounts Payable, Current 3.03M USD +25.9%
Liabilities, Current 28.7M USD -4.37%
Operating Lease, Liability, Noncurrent 43.4M USD -10.5%
Other Liabilities, Noncurrent 395K USD +16.2%
Liabilities 72.5M USD -8.04%
Accumulated Other Comprehensive Income (Loss), Net of Tax 649K USD -64.4%
Retained Earnings (Accumulated Deficit) -863M USD -17.4%
Stockholders' Equity Attributable to Parent 348M USD -22.7%
Liabilities and Equity 420M USD -20.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.6M USD +5.1%
Net Cash Provided by (Used in) Financing Activities 6.93M USD +3687%
Net Cash Provided by (Used in) Investing Activities 34.3M USD +244%
Common Stock, Shares Authorized 800M shares 0%
Common Stock, Shares, Issued 284M shares +0.36%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 2.74M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 70.6M USD +1.94%
Deferred Tax Assets, Valuation Allowance 180M USD +25.2%
Deferred Tax Assets, Gross 190M USD +21.7%
Operating Lease, Liability 48.3M USD -8.78%
Payments to Acquire Property, Plant, and Equipment 83K USD +97.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -129M USD +17.8%
Lessee, Operating Lease, Liability, to be Paid 64.8M USD -12.4%
Property, Plant and Equipment, Gross 26M USD -1.47%
Operating Lease, Liability, Current 4.89M USD +9.78%
Lessee, Operating Lease, Liability, to be Paid, Year Two 9.2M USD +0.32%
Lessee, Operating Lease, Liability, to be Paid, Year One 9.04M USD +0.12%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16.5M USD -21.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 9.28M USD +0.85%
Deferred Tax Assets, Operating Loss Carryforwards 70.1M USD +18.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 80M shares 0%
Unrecognized Tax Benefits 5.41M USD +32.1%
Lessee, Operating Lease, Liability, to be Paid, Year Four 9.57M USD +3.18%
Operating Lease, Payments 1.5M USD -28.6%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 3.23M USD -16.8%
Share-based Payment Arrangement, Expense 25.4M USD -5.29%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%